Becton, Dickinson and Company's CEO Salary
- Thomas E. Polen Chairman, Chief Executive Officer and President at Becton, Dickinson and Company, received a total compensation of $17.13 M in 2025.
- Christopher J. DelOrefice Executive Vice President and Chief Financial Officer at Becton, Dickinson and Company, received a total compensation of $5.88 M in 2025.
- Michael C. Feld Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment at Becton, Dickinson and Company, received a total compensation of $4.10 M in 2025.
- Michael D. Garrison Executive Vice President and President, Medical Essentials and BioPharma Systems Segments at Becton, Dickinson and Company, received a total compensation of $3.65 M in 2025.
- Richard E. Byrd Executive Vice President and President, Interventional Segment at Becton, Dickinson and Company, received a total compensation of $3.40 M in 2025.
Becton, Dickinson and Company's CEO salary and other executives compensation in 2025 was as follows:
Executive Compensation Summary Table
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Thomas E. Polen Chairman, Chief Executive Officer and President | $17.13 M | $17.31 M | $17.31 M |
| Base Salary | $1.40 M | $1.35 M | $1.32 M |
| Incentive Plan Compensation | $1.85 M | $2.11 M | $1.89 M |
| All Other Compensation | $577.95 K | $613.43 K | $570.17 K |
| Stock Award | $9.99 M | $9.24 M | $9.49 M |
| Christopher J. DelOrefice Executive Vice President and Chief Financial Officer | $5.88 M | $5.63 M | $5.21 M |
| Base Salary | $837.50 K | $785.40 K | $736.20 K |
| Incentive Plan Compensation | $722.50 K | $906.40 K | $774.97 K |
| All Other Compensation | $135.77 K | $85.58 K | $85.46 K |
| Stock Award | $3.14 M | $2.69 M | $2.53 M |
| Michael C. Feld Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment | $4.10 M | - | - |
| Base Salary | $775.00 K | - | - |
| Incentive Plan Compensation | $533.59 K | - | - |
| All Other Compensation | $602.05 K | - | - |
| Stock Award | $1.64 M | - | - |
| Michael D. Garrison Executive Vice President and President, Medical Essentials and BioPharma Systems Segments | $3.65 M | $3.62 M | $3.65 M |
| Base Salary | $768.75 K | $731.25 K | $675.00 K |
| Incentive Plan Compensation | $533.59 K | $556.20 K | $599.57 K |
| All Other Compensation | $160.99 K | $168.08 K | $548.17 K |
| Stock Award | $1.64 M | $1.51 M | $1.28 M |
| Richard E. Byrd Executive Vice President and President, Interventional Segment | $3.40 M | $3.27 M | - |
| Base Salary | $756.25 K | $681.25 K | - |
| Incentive Plan Compensation | $592.88 K | $648.90 K | - |
| All Other Compensation | $149.26 K | $253.56 K | - |
| Stock Award | $1.43 M | $1.18 M | - |
| Thomas E. Polen Chairman of the Board, Chief Executive Officer and President | - | $17.31 M | $17.31 M |
| Base Salary | - | $1.35 M | $1.32 M |
| Incentive Plan Compensation | - | $2.11 M | $1.89 M |
| All Other Compensation | - | $613.43 K | $570.17 K |
| Stock Award | - | $9.24 M | $9.49 M |
| Michael D. Garrison Executive Vice President and President, Medical Segment | - | $3.62 M | $3.65 M |
| Base Salary | - | $731.25 K | $675.00 K |
| Incentive Plan Compensation | - | $556.20 K | $599.57 K |
| All Other Compensation | - | $168.08 K | $548.17 K |
| Stock Award | - | $1.51 M | $1.28 M |
| Shana Neal Executive Vice President and Chief People Officer | - | $3.31 M | $5.89 M |
| Base Salary | - | $622.58 K | $606.66 K |
| Incentive Plan Compensation | - | $484.47 K | $433.83 K |
| All Other Compensation | - | $280.27 K | $369.91 K |
| Stock Award | - | $1.34 M | $3.47 M |
| David B. Hickey Executive Vice President and President, Life Sciences Segment | - | - | $3.35 M |
| Base Salary | - | - | $649.29 K |
| Incentive Plan Compensation | - | - | $422.52 K |
| All Other Compensation | - | - | $151.02 K |
| Stock Award | - | - | $1.49 M |
